UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Autoimmune Neurogenic Dysphagia

Dysphagia, 2022-06, Vol.37 (3), p.473-487

2022

Volltextzugriff (PDF)

Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep Sequencing

The Journal of immunology (1950), 2017-02, Vol.198 (4), p.1460-1473

2017

Volltextzugriff (PDF)

The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data

International journal of molecular sciences, 2022-08, Vol.23 (15), p.8077

2022

Volltextzugriff (PDF)

Durability of the Rituximab Response in Acetylcholine Receptor Autoantibody-Positive Myasthenia Gravis

JAMA neurology, 2017-01, Vol.74 (1), p.60

2017

Volltextzugriff (PDF)

Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravis

The Journal of experimental medicine, 2020-12, Vol.217 (12)

2020

Volltextzugriff (PDF)

Cortical involvement and leptomeningeal inflammation in myelin oligodendrocyte glycoprotein antibody disease: A three-dimensional fluid-attenuated inversion recovery MRI study

Multiple sclerosis, 2022-04, Vol.28 (5), p.718-729

2022

Volltextzugriff (PDF)

IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients

Journal of neuroimmunology, 2021-12, Vol.361, p.577759-577759, Article 577759

2021

Volltextzugriff (PDF)

Autoantibody-producing plasmablasts after B cell depletion identified in muscle-specific kinase myasthenia gravis

JCI insight, 2017-09, Vol.2 (17)

2017

Volltextzugriff (PDF)

Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study

Clinical and experimental medicine, 2023-10, Vol.23 (6), p.2885-2894

2023

Volltextzugriff (PDF)

Belly-born B cells bathe the brain

Science immunology, 2019-02, Vol.4 (32)

2019

Volltextzugriff (PDF)

Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases

Neurotherapeutics, 2022-04, Vol.19 (3), p.691-710

2022

Volltextzugriff (PDF)

The Pathophysiological Mechanism Is an Independent Predictor of Long-Term Outcome in Stroke Patients with Large Vessel Atherosclerosis

Journal of stroke and cerebrovascular diseases, 2015-11, Vol.24 (11), p.2580-2587

2015

Volltextzugriff (PDF)

Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders

Nature reviews. Neurology, 2015-03, Vol.11 (3), p.143-156

2015

Volltextzugriff (PDF)

B-Cell-Directed Therapies: A New Era in Multiple Sclerosis Treatment

Canadian journal of neurological sciences, 2023-05, Vol.50 (3), p.355-364

2023

Volltextzugriff (PDF)

GAD-positive Stiff Person Syndrome (GAD-SPS) with Autoimmune Retinopathy (AR): Argonaute-2 but not GAD as Potential Targeted Retinal Antigen

Neurology, 2024-10, Vol.103 (7_Supplement_1)

2024

Volltextzugriff (PDF)

The role of complement and complement therapeutics in neuromyelitis optica spectrum disorders

Expert review of clinical immunology, 2022-09, Vol.18 (9), p.933-945

2022

Volltextzugriff (PDF)

B cells in the pathophysiology of myasthenia gravis

Muscle & nerve, 2018-02, Vol.57 (2), p.172-184

2018

Volltextzugriff (PDF)

Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production

Brain (London, England : 1878), 2019-06, Vol.142 (6), p.1598-1615

2019

Volltextzugriff (PDF)

Flame (v2.0): advanced integration and interpretation of functional enrichment results from multiple sources

Bioinformatics (Oxford, England), 2023-08, Vol.39 (8)

2023

Volltextzugriff (PDF)

Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production

The Journal of immunology (1950), 2016-03, Vol.196 (5), p.2075-2084

2016

Volltextzugriff (PDF)

Multiple faces of multiple sclerosis in the era of highly efficient treatment modalities: Lymphopenia and switching treatment options challenges daily practice

International immunopharmacology, 2023-12, Vol.125, p.111192-111192, Article 111192

2023

Volltextzugriff (PDF)

Therapeutic considerations in a case of progressive encephalomyelitis with rigidity and myoclonus

Journal of the neurological sciences, 2020-09, Vol.416, p.116993-116993, Article 116993

2020

Volltextzugriff (PDF)

Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis

Neurology : neuroimmunology & neuroinflammation, 2015-08, Vol.2 (4), p.e131-e131

2015

Volltextzugriff (PDF)

Mechanisms underlying B cell immune dysregulation and autoantibody production in MuSK myasthenia gravis

Annals of the New York Academy of Sciences, 2018-01, Vol.1412 (1), p.154-165

2018

Volltextzugriff (PDF)

Recurrent Optic Neuritis (rON) is characterised by Anti-MOG Antibodies: A follow-up study (P5.274)

Neurology, 2015-04, Vol.84 (14_supplement)

2015

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(38)

Publikationsform

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Autoimmune Neurogenic Dysphagia

Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep Sequencing

The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data

Durability of the Rituximab Response in Acetylcholine Receptor Autoantibody-Positive Myasthenia Gravis

Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravis

Cortical involvement and leptomeningeal inflammation in myelin oligodendrocyte glycoprotein antibody disease: A three-dimensional fluid-attenuated inversion recovery MRI study

IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients

Autoantibody-producing plasmablasts after B cell depletion identified in muscle-specific kinase myasthenia gravis

Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study

Belly-born B cells bathe the brain

Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases

The Pathophysiological Mechanism Is an Independent Predictor of Long-Term Outcome in Stroke Patients with Large Vessel Atherosclerosis

Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders

B-Cell-Directed Therapies: A New Era in Multiple Sclerosis Treatment

GAD-positive Stiff Person Syndrome (GAD-SPS) with Autoimmune Retinopathy (AR): Argonaute-2 but not GAD as Potential Targeted Retinal Antigen

The role of complement and complement therapeutics in neuromyelitis optica spectrum disorders

B cells in the pathophysiology of myasthenia gravis

Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production

Flame (v2.0): advanced integration and interpretation of functional enrichment results from multiple sources

Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production

Multiple faces of multiple sclerosis in the era of highly efficient treatment modalities: Lymphopenia and switching treatment options challenges daily practice

Therapeutic considerations in a case of progressive encephalomyelitis with rigidity and myoclonus

Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis

Mechanisms underlying B cell immune dysregulation and autoantibody production in MuSK myasthenia gravis

Recurrent Optic Neuritis (rON) is characterised by Anti-MOG Antibodies: A follow-up study (P5.274)

Suchergebnisse filtern